Christian Zurth

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

Christian Zurth, Mikko Koskinen, Robert E. Fricke et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2019 · 94 citations · Full text

Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial

Neal D. Shore, Christian Zurth, Robert E. Fricke et al. · Targeted Oncology · 2019 · 90 citations · Full text

Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy Women

Christine Klipping, Ingrid Duijkers, Ageeth Remmers et al. · The Journal of Clinical Pharmacology · 2011 · 88 citations

Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases

Keisuke Yoshida, Tomohiro Kaneta, Shoko Takano et al. · Annals of Nuclear Medicine · 2016 · 61 citations · Full text

Higher blood–brain barrier penetration of [¹⁴C]apalutamide and [¹⁴C]enzalutamide compared to [¹⁴C]darolutamide in rats using whole-body autoradiography.

Christian Zurth, Steffen Sandman, Dagmar Trummel et al. · Journal of Clinical Oncology · 2019 · 51 citations

Moderate Bbb Penetration, Pharmacotherapy, Experimental Pharmacology +22